Article
Hairy cell leukemia: update and current therapeutic approach.
Current opinion in hematology - 1 Jul 2015
Salam Latif, Abdel-Wahab Omar
Abstract excerpt
PURPOSE OF REVIEW: In this review, we discuss the pathogenesis and standard therapeutic approach to hairy cell leukaemia (HCL) as well as newer targeted therapies under investigation showing promising end-points in treating HCL. RECENT FINDINGS: HCL is an indolent B-cell leukaemia. Historically, HCL patients have achieved excellent response to purine nucleoside analogues and single purine analogue treatment with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
